Nebivolol may restore damaged cardiovascular functions in African Americans

	Tweet

Nebivolol, a drug for treatment of High Blood Pressure available in Europe, may restore damaged cardiovascular functions in African Americans, according to a recent laboratory study at Ohio University.

Tadeusz Malinski, Marvin & Ann Dilley White Professor of Chemistry and Biochemistry, found that the drug, currently under review by the U.S. Food and Drug Administration, acts on the level of oxidants lining the cardiovascular system and can restore levels of nitric oxide and reduce oxidative stress. A deficiency in nitric oxide and high oxidative stress can cause a variety of health problems, including heart attacks, stroke and heart failure, as well as kidney failure and diabetes.

The study was published in a recent issue of Circulation, a journal of the American Heart Association, and involved collaborators from Harvard Medical School and Elucida Research in Massachusetts.

In a healthy cardiovascular system, there is a fine balance between nitric oxide and oxidative stress. Nitric oxide controls blood flow and relaxes blood vessels, which lowers blood pressure. The nitric oxide is released by endothelial cells, a monolayer of cells lining blood vessels.

About a year ago, Malinski’s research team discovered that African Americans potentially have a better nitric oxide generating system than people of other ethnicities, the researcher reported. Due to a molecular deficiency, however, the system becomes self-destructive by also generating high concentrations of oxidative species that diminish the level of good nitric oxide and increase oxidative stress to the level observed in a diseased state. The prevalence of this problem can be blamed for the high mortality rate of African Americans between 43 and 64 years of age, which is five to six times higher than that of other ethnic groups, Malinski said.

That’s where nebivolol may come in. The drug is part of a new generation of beta-blockers, which are standard treatments for High Blood Pressure. The researchers studied multiple versions of these beta-blockers and found that, besides lowering blood pressure, nebivolol also restored the function of the nitric oxide system in the cell samples.

“It is very rare that we see a dual positive effect of a drug in medical treatments,” Malinski said.

In the recent study, scientists used nanosensors to test levels of nitric oxide, as well as molecules involved in the oxidative stress, in single cells from donors of various ethnic backgrounds. Using nanosensors 1,000 times smaller than a human hair, the researchers could take real-time measurements of nitric oxide levels before and after nebivolol was administered. This nanomedical approach allowed the research to progress much faster than it would have with traditional methods of measuring nitric oxide levels.

“The drug restores correct balance between good nitric oxide and damaging oxidative stress, and can in fact restore the vital function of endothelial tissue to a level similar in other ethnic groups,” Malinski said of his team’s findings. “Previous treatments only slowed progression of the damage, while nebivolol may actually be able to correct the problems.”

Malinski and other researchers are currently investigating possible uses of the drug to prevent damage to the cardiovascular system.

http://www.ohio.edu

RELATED STORIES:
Scientists turn skin cells into beating heart muscle   Too many people get angioplasties, study suggests   New Blood Thinner May Lower Chances of Clots in High-Risk Heart Patients: FDA   Heart Damage After Chemo Linked to Stress in Cardiac Cells   What’s good or bad for the heart, may be the same for the brain   Warfarin in Heart Failure   Increased Sudden Cardiac Death Rate Among HIV Patients   Air pollution level changes in Beijing linked with biomarkers of cardiovascular disease   Lack of basic evidence hampering prevention of sudden heart attacks in sport   Blacks Less Likely to Get Help on Scene After Cardiac Arrest: Study   Heart attack patients taken to PCI hospitals first treated faster   Cameron Health’s under-skin ICD safe, effective

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]